SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311229 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Claudia Laarman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Public Health and the Environment received from the Ministry of Health, Welfare, and Sports for surveillance and research on the SARS-Co….
Abstract (Originalsprache)
Introduction
Most studies on risk factors for a SARS-CoV-2 infection were conducted in the pre-vaccination era with many non-pharmaceutical prevention measures in place. We investigated risk factors for symptomatic SARS-CoV-2 infections in vaccinated persons in a period with a varying degree of prevention measures.
Methods
In a test-negative case control study among vaccinated adults attending community COVID-19 testing locations between June 1 st 2021 till February 28 th 2022, we compared symptomatic cases with symptomatic controls (to study risk factors specific for SARS-CoV-2) and with asymptomatic controls (to study risk factors that could apply to respiratory infections in general). We examined potential risk factors including household composition and mitigation behaviour by logistic regression, adjusting for age, sex, and week of testing.
Results
Risk factors for a positive SARS-CoV-2 test when symptomatic cases were compared to symptomatic controls were: having a household size of more than 4 (adjusted odds ratio: 1.47; 95% CI 1.14–1.92), being a healthcare worker (1.27;1.18–1.47), and visiting busy locations outside (1.49;1.19–1.87). When symptomatic cases were compared to asymptomatic controls, a household size of more than 4 members (1.71;1.25–2.33), living with children aged 0–12 (1.59;1.12–2.26), visiting busy locations outside (1.64;1.24–2.17) were independent risk factors for a positive SARS-CoV-2 test. Risk factors for separate periods and waves differed from the study period as a whole.
Conclusion
This study was conducted in a period with a varying degree of prevention measures. Among vaccinated individuals, we identified several SARS-CoV-2 specific risk factors and SARS-CoV-2 risk factors that could be more general for respiratory infections. For SARS-CoV-2 transmission more attention could be given to visiting busy outdoor locations, having a household size that consists of more than 4 persons, being a healthcare worker, and living with children aged 0–12. Risk factors varied with different phases in the pandemic, emphasizing the importance of repeated assessment of risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
ORCID-Profile: Mirjam J Knol
Förderung
- National Institute for Public Health and the Environment received from the Ministry of Health, Welfare, and Sports for surveillance and research on the SARS-Co…
Zitieren
APA
Laarman, C., Hahné, S. J., de Melker, H. E., & Knol, M. J. (2024). SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. PLOS ONE. https://doi.org/10.1371/journal.pone.0311229
Vancouver
Laarman C, Hahné SJ, de Melker HE, Knol MJ. SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. PLOS ONE. 2024. doi:10.1371/journal.pone.0311229
BibTeX
@article{Laarman2024,
author = {Laarman, Claudia and Hahné, Susan J and de Melker, Hester E and Knol, Mirjam J},
title = {SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311229}
}
EUVIMED